March 26, 2020 / 8:47 PM / 9 days ago

BRIEF-Translate Bio Provides Mrt5005 Program Updates

March 26 (Reuters) - Translate Bio Inc:

* TRANSLATE BIO PROVIDES MRT5005 PROGRAM UPDATES

* TRANSLATE BIO INC - FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION FOR MRT5005 FOR TREATMENT OF CYSTIC FIBROSIS

* TRANSLATE BIO INC - RESPONSE TO COVID-19 PANDEMIC ANTICIPATED TO CAUSE INTERRUPTIONS IN CERTAIN CLINICAL TRIAL OPERATIONS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below